Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aprotinin Treatment of Acute Respiratory Distress Syndrome: a Multicenter, Double-blind, Placebo-controlled, Phase III Trial

NCT07317050 is registered in ClinicalTrials.gov with Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion as lead sponsor.

NCT NCT07317050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07317050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aprotinin Treatment of Acute Respiratory Distress Syndrome: a Multicenter, Double-blind, Placebo-controlled, Phase III Trial
Lead sponsor
Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion
Phase
Phase 3
Overall status
Recruiting
Start date
June 18, 2026
Completion date
March 1, 2030
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome (ards)